JoanHSchillerMD

PubMed

• 7 citations
  The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer.
  Barbara J. Gitlitz, Silvia Novello, Tiziana Vavalà, Marisa A. Bittoni, Alicia Sable-Hunt, Dean Pavlick, Robert Hsu, S. Lani Park, Matthew Cooke, Amy Moore, Alexa B. Sc...> ;JTO Clinical and Research Reports. 2021 Jul 1
• 3 citations
  Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
  Conor E. Steuer, Opeyemi Jegede, Suzanne E. Dahlberg, Heather A. Wakelee, Steven M. Keller, William J. Tester, David R. Gandara, Stephen L. Graziano, Alex A. Adjei, Ch...> ;Journal of Thoracic Oncology. 2021 Jun 1
• 135 citations
  Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
  Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker Jr, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, Ishma...> ;Journal of Clinical Oncology. 2021 Mar 20
• 5 citations
  Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (N...
  Jyoti D. Patel, Ju Whei Lee, David P. Carbone, Henry N. Wagner, Anil Shanker, Maria Teresa P. de Aquino, Leora Horn, Melissa Lynne Johnson, David E. Gerber, Jane Jijun...> ;Clinical Lung Cancer. 2020 Jun 12
• 139 citations
  Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
  Nasser H Hanna, Bryan J Schneider, Sarah Temin, Sherman Baker Jr, Julie Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, Ishmael...> ;Journal of Clinical Oncology. 2020 May 10
• 39 citations
  Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508
  Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani, Joel N. Saltzman, Nathan A. Pennell, Gopakumar S. Nambudiri, John McCann, Jerome D. Winegarden, Mohammed ...> ;Journal of Clinical Oncology. 2019 Jul 30
• 10 citations
  Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.
  Tao Wang, Rong Lu, Sunny Lai, Joan H. Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E. Gerber, David H. Johnson, Guanghua Xiao, Yang Xie> ;Cancer Informatics. 2019 Apr 5
• 16 citations
  A New Standard of Care for Advanced Lung Cancer
  Joan H. Schiller> ;The New England Journal of Medicine. 2018 May 30
• 21 citations
  The importance of greater speed in drug development for advanced malignancies.
  David J. Stewart, Andrew A. Stewart, Paul Wheatley-Price, Gerald Batist, Hagop M. Kantarjian, Joan H. Schiller, Mark Clemons, John Peter Bradford, Laurel Gillespie, Ra...> ;Cancer Medicine. 2018 May 1
• 229 citations
  Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
  Nasser Hanna, David Johnson, Sarah Temin, Sherman Baker Jr, Julie Brahmer, Peter M Ellis, Giuseppe Giaccone, Paul J Hesketh, Ishmael Jaiyesimi, Natasha B Leighl, Grego...> ;Journal of Clinical Oncology. 2017 Oct 20
• 3 citations
  Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients
  Thomas J. Smith, Nasser H. Hanna, David H. Johnson, Sherman Baker, William A. Biermann, Julie Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiy...> ;Journal of Oncology Practice. 2017 Oct 5
• 45 citations
  Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity
  Sandra Garcia, Ajit Kumar Bisen, Jingsheng Yan, Xian Jin Xie, Suresh S. Ramalingam, Joan H. Schiller, David H. Johnson, David E. Gerber> ;Journal of Thoracic Oncology. 2017 Oct 1
• 54 citations
  Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygen...
  Martin J. Edelman, Xiaofei Wang, Lydia Hodgson, Richard T. Cheney, Maria Q. Baggstrom, Sachdev P. Thomas, Ajeet Gajra, Erin M. Bertino, Karen L. Reckamp, Julian R. Mol...> ;Journal of Clinical Oncology. 2017 May 10
• 51 citations
  Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies
  Hao Tang, Siling Wang, Guanghua Xiao, Joan H. Schiller, Vassiliki A. Papadimitrakopoulou, John D. Minna, I. I. Wistuba, Yang Xie> ;Annals of Oncology. 2017 Apr 1
• 32 citations
  Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
  Robin E. Frink, Michael Peyton, Joan H. Schiller, Adi F. Gazdar, Jerry W. Shay, John D. Minna> ;Oncotarget. 2016 May 13
• 4 citations
  Study Design Issues and Early Stage Non–Small Cell Lung Cancer
  Joan H. Schiller> ;Clinical Cancer Research. 2005 Jul 1
• 6 citations
  Clinical Trial Design Issues in the Era of Targeted Therapies
  Joan H. Schiller> ;Clinical Cancer Research. 2004 Jun 15
• 3 citations
  Epidermal growth factor receptor as a therapeutic target in lung cancer.
  Joan H. Schiller> ;Seminars in Respiratory and Critical Care Medicine. 2004 Jan 1
• Adjuvant systemic therapies in early-stage non-small-cell lung cancer.
  Joan H. Schiller> ;Clinical Lung Cancer. 2003 Sep 1
• 27 citations
  New directions for ZD1839 in the treatment of solid tumors
  Joan H. Schiller> ;Seminars in Oncology. 2003 Feb 1
• Join now to see all